Lucas Baranowski's questions to Azenta Inc (AZTA) leadership • Q4 2024
Question
Lucas Baranowski, on behalf of Paul Knight, asked for a potential timeline for the closing of the B Medical divestiture. He also inquired whether capital expenditures would trend lower following the completion of the transaction.
Answer
CFO Herman Cueto indicated that the sale of B Medical is expected to be a first-half 2025 event. Regarding capital expenditures, he suggested CapEx would likely remain in the 4-6% of sales range for the remaining company. CEO John P. Marotta added that all capital deployment, including CapEx, will be scrutinized under the new, rigorous capital allocation framework focused on generating double-digit returns.